These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 15687234)

  • 1. The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells.
    Guzman ML; Rossi RM; Karnischky L; Li X; Peterson DR; Howard DS; Jordan CT
    Blood; 2005 Jun; 105(11):4163-9. PubMed ID: 15687234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloperoxidase expression as a potential determinant of parthenolide-induced apoptosis in leukemia bulk and leukemia stem cells.
    Kim YR; Eom JI; Kim SJ; Jeung HK; Cheong JW; Kim JS; Min YH
    J Pharmacol Exp Ther; 2010 Nov; 335(2):389-400. PubMed ID: 20699435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron Oxide Nanoparticles Combined with Cytosine Arabinoside Show Anti-Leukemia Stem Cell Effects on Acute Myeloid Leukemia by Regulating Reactive Oxygen Species.
    Dou J; Li L; Guo M; Mei F; Zheng D; Xu H; Xue R; Bao X; Zhao F; Zhang Y
    Int J Nanomedicine; 2021; 16():1231-1244. PubMed ID: 33633448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells.
    Guzman ML; Rossi RM; Neelakantan S; Li X; Corbett CA; Hassane DC; Becker MW; Bennett JM; Sullivan E; Lachowicz JL; Vaughan A; Sweeney CJ; Matthews W; Carroll M; Liesveld JL; Crooks PA; Jordan CT
    Blood; 2007 Dec; 110(13):4427-35. PubMed ID: 17804695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guaianolide sesquiterpene lactones, a source to discover agents that selectively inhibit acute myelogenous leukemia stem and progenitor cells.
    Zhang Q; Lu Y; Ding Y; Zhai J; Ji Q; Ma W; Yang M; Fan H; Long J; Tong Z; Shi Y; Jia Y; Han B; Zhang W; Qiu C; Ma X; Li Q; Shi Q; Zhang H; Li D; Zhang J; Lin J; Li LY; Gao Y; Chen Y
    J Med Chem; 2012 Oct; 55(20):8757-69. PubMed ID: 22985027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preferential induction of apoptosis for primary human leukemic stem cells.
    Guzman ML; Swiderski CF; Howard DS; Grimes BA; Rossi RM; Szilvassy SJ; Jordan CT
    Proc Natl Acad Sci U S A; 2002 Dec; 99(25):16220-5. PubMed ID: 12451177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of agents that eradicate leukemia stem cells using an in silico screen of public gene expression data.
    Hassane DC; Guzman ML; Corbett C; Li X; Abboud R; Young F; Liesveld JL; Carroll M; Jordan CT
    Blood; 2008 Jun; 111(12):5654-62. PubMed ID: 18305216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The sesquiterpene lactone parthenolide induces selective apoptosis of B-chronic lymphocytic leukemia cells in vitro.
    Steele AJ; Jones DT; Ganeshaguru K; Duke VM; Yogashangary BC; North JM; Lowdell MW; Kottaridis PD; Mehta AB; Prentice AG; Hoffbrand AV; Wickremasinghe RG
    Leukemia; 2006 Jun; 20(6):1073-9. PubMed ID: 16628188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disulfiram/copper selectively eradicates AML leukemia stem cells in vitro and in vivo by simultaneous induction of ROS-JNK and inhibition of NF-κB and Nrf2.
    Xu B; Wang S; Li R; Chen K; He L; Deng M; Kannappan V; Zha J; Dong H; Wang W
    Cell Death Dis; 2017 May; 8(5):e2797. PubMed ID: 28518151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective activity of the histone deacetylase inhibitor AR-42 against leukemia stem cells: a novel potential strategy in acute myelogenous leukemia.
    Guzman ML; Yang N; Sharma KK; Balys M; Corbett CA; Jordan CT; Becker MW; Steidl U; Abdel-Wahab O; Levine RL; Marcucci G; Roboz GJ; Hassane DC
    Mol Cancer Ther; 2014 Aug; 13(8):1979-90. PubMed ID: 24934933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parthenolide and DMAPT induce cell death in primitive CML cells through reactive oxygen species.
    Flores-Lopez G; Moreno-Lorenzana D; Ayala-Sanchez M; Aviles-Vazquez S; Torres-Martinez H; Crooks PA; Guzman ML; Mayani H; Chávez-González A
    J Cell Mol Med; 2018 Oct; 22(10):4899-4912. PubMed ID: 30079458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antineoplastic mechanisms of niclosamide in acute myelogenous leukemia stem cells: inactivation of the NF-kappaB pathway and generation of reactive oxygen species.
    Jin Y; Lu Z; Ding K; Li J; Du X; Chen C; Sun X; Wu Y; Zhou J; Pan J
    Cancer Res; 2010 Mar; 70(6):2516-27. PubMed ID: 20215516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antineoplastic effects and mechanisms of micheliolide in acute myelogenous leukemia stem cells.
    Ji Q; Ding YH; Sun Y; Zhang Y; Gao HE; Song HN; Yang M; Liu XL; Zhang ZX; Li YH; Gao YD
    Oncotarget; 2016 Oct; 7(40):65012-65023. PubMed ID: 27542251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MTH1 Inhibitor TH1579 Induces Oxidative DNA Damage and Mitotic Arrest in Acute Myeloid Leukemia.
    Sanjiv K; Calderón-Montaño JM; Pham TM; Erkers T; Tsuber V; Almlöf I; Höglund A; Heshmati Y; Seashore-Ludlow B; Nagesh Danda A; Gad H; Wiita E; Göktürk C; Rasti A; Friedrich S; Centio A; Estruch M; Våtsveen TK; Struyf N; Visnes T; Scobie M; Koolmeister T; Henriksson M; Wallner O; Sandvall T; Lehmann S; Theilgaard-Mönch K; Garnett MJ; Östling P; Walfridsson J; Helleday T; Warpman Berglund U
    Cancer Res; 2021 Nov; 81(22):5733-5744. PubMed ID: 34593524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multilineage outgrowth of both malignant and normal hemopoietic progenitor cells from individual chronic myeloid leukemia patients in immunodeficient mice.
    Verstegen MM; Cornelissen JJ; Terpstra W; Wagemaker G; Wognum AW
    Leukemia; 1999 Apr; 13(4):618-28. PubMed ID: 10214871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preferential eradication of acute myelogenous leukemia stem cells by fenretinide.
    Zhang H; Mi JQ; Fang H; Wang Z; Wang C; Wu L; Zhang B; Minden M; Yang WT; Wang HW; Li JM; Xi XD; Chen SJ; Zhang J; Chen Z; Wang KK
    Proc Natl Acad Sci U S A; 2013 Apr; 110(14):5606-11. PubMed ID: 23513221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of cantharidins on leukemic stem cells.
    Dorn DC; Kou CA; Png KJ; Moore MA
    Int J Cancer; 2009 May; 124(9):2186-99. PubMed ID: 19123473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A New Strategy to Target Acute Myeloid Leukemia Stem and Progenitor Cells Using Chidamide, a Histone Deacetylase Inhibitor.
    Li Y; Chen K; Zhou Y; Xiao Y; Deng M; Jiang Z; Ye W; Wang X; Wei X; Li J; Liang J; Zheng Z; Yao Y; Wang W; Li P; Xu B
    Curr Cancer Drug Targets; 2015; 15(6):493-503. PubMed ID: 26282548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SYK inhibition targets acute myeloid leukemia stem cells by blocking their oxidative metabolism.
    Polak A; Bialopiotrowicz E; Krzymieniewska B; Wozniak J; Stojak M; Cybulska M; Kaniuga E; Mikula M; Jablonska E; Gorniak P; Noyszewska-Kania M; Szydlowski M; Piechna K; Piwocka K; Bugajski L; Lech-Maranda E; Barankiewicz J; Kolkowska-Lesniak A; Patkowska E; Glodkowska-Mrowka E; Baran N; Juszczynski P
    Cell Death Dis; 2020 Nov; 11(11):956. PubMed ID: 33159047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feverfew: weeding out the root of leukaemia.
    Guzman ML; Jordan CT
    Expert Opin Biol Ther; 2005 Sep; 5(9):1147-52. PubMed ID: 16120045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.